Business Context and Reporting Period
This Form 8-K, dated January 9, 2023, reports a corporate name change from Sema4 Holdings Corp. to GeneDx Holdings Corp. and the adoption of amended bylaws. The filing also incorporates a press release containing preliminary, unaudited pro forma financial results for the year ended 2022 and guidance for 2023. The company expects its Class A common stock to begin trading under the new ticker symbol "WGS" on January 10, 2023.
Key Financial Metrics
The filing references a press release (Exhibit 99.1) containing preliminary, unaudited pro forma revenue, test result volumes, and pro forma adjusted gross margins for 2022. These figures assume the combination of GeneDx and Sema4 for the entirety of 2021 and 2022 and exclude revenues and costs from exited reproductive health and somatic tumor testing businesses. The text of this 8-K does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
- Corporate Name: Changed from Sema4 Holdings Corp. to GeneDx Holdings Corp. effective January 9, 2023.
- Trading Symbol: Class A common stock ticker changed from "SMFR" to "WGS" on the Nasdaq Global Select Market.
- Bylaws: Amended and restated bylaws were adopted to align with Delaware General Corporation Law (DGCL) amendments, SEC Universal Proxy Rules, and to update governance procedures regarding stockholder meetings and nominations.
Guidance, Outlook, and Risks
The company issued guidance regarding expectations for 2023 in the referenced press release, though specific targets are not detailed in this filing text. The bylaw amendments introduce new procedural requirements for stockholder nominations and proxy solicitations, including restrictions on the number of nominees and requirements for interviews. A new exclusive forum provision designates the Court of Chancery of the State of Delaware (or the U.S. District Court for the District of Delaware) as the sole forum for specific corporate governance claims.
Investor Verification Checklist
- Verify the specific numerical values for 2022 pro forma revenue, test volumes, and adjusted gross margins in the attached Press Release (Exhibit 99.1).
- Confirm the 2023 financial guidance details provided in the press release.
- Review the full text of the Amended and Restated Bylaws (Exhibit 3.2) for specific changes to stockholder rights and meeting procedures.
- Monitor the transition of the stock ticker from SMFR to WGS on January 10, 2023.